A radioimmunoassay has been developed which enables accurate determination of haloperidol in human serum. Antiserum was prepared by immunizing guinea pigs with haloperidol (O-carboxymethyl)oxime derivative (III) coupled with bovine serum albumin. With the antiserum, 3H-haloperidol and dextran-coated charcoal, the assay of haloperidol in serum was possible over a concentration range of 1 to 50 ng/ml, using 0.1 ml of human serum without the need of an extraction procedure. Data obtained by radioimmunoassay are in good agreement with those obtained by gas chromatography. No appreciable cross-reactivity was observed neither with haloperidol metabolites nor with other butyrophenone neuroleptics. Serum levels of haloperidol in schizophrenic patients receiving single oral dosing (6 mg/subject) have also been determined. © 1980, The Pharmaceutical Society of Japan. All rights reserved.
CITATION STYLE
Suzuki, H., Itoh, H., Iwaisaki, M., Sekine, Y., Kagemoto, A., Utsui, Y., … Yagi, G. (1980). Determination of haloperidol in human serum by radioimmunoassay. Journal of Pharmacobio-Dynamics, 3(5), 250–257. https://doi.org/10.1248/bpb1978.3.250
Mendeley helps you to discover research relevant for your work.